Normal Ovarian Reserve During Long-Term Osimertinib Therapy in a Patient With Li-Fraumeni Syndrome: A Case Report and Literature Review
Cureus · 19.06.2026
DOI: 10.7759/cureus.111169 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 19.06.2026. Verfasst von Sana M Salih und 3 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Endocrinology and Infertility, University of Chicago, Chicago, USA. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Reproductive Endocrinology and Infertility, University of Chicago, Chicago, USA.
- Obstetrics and Gynaecology, University of Chicago, Chicago, USA.
- Internal Medicine, LewisGale Medical Center, Salem, USA.
- Hematology Oncology, Lurie Children's Hospital, Chicago, USA.
Zitieren
APA
Salih, S. M., Atmakuri, A., Elsarrag, S. Z., & Schwartz, L. F. (2026). Normal Ovarian Reserve During Long-Term Osimertinib Therapy in a Patient With Li-Fraumeni Syndrome: A Case Report and Literature Review. Cureus. https://doi.org/10.7759/cureus.111169
Vancouver
Salih SM, Atmakuri A, Elsarrag SZ, Schwartz LF. Normal Ovarian Reserve During Long-Term Osimertinib Therapy in a Patient With Li-Fraumeni Syndrome: A Case Report and Literature Review. Cureus. 2026. doi:10.7759/cureus.111169
BibTeX
@article{Salih2026,
author = {Salih, Sana M and Atmakuri, Aishwarya and Elsarrag, Selma Z and Schwartz, Lindsay F},
title = {Normal Ovarian Reserve During Long-Term Osimertinib Therapy in a Patient With Li-Fraumeni Syndrome: A Case Report and Literature Review},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.111169}
}
EUVIMED